Case report: fulminant hepatitis C viral infection after allogeneic bone marrow transplantation.
The authors describe two patients with acute leukemia who died of fulminant hepatitis caused by hepatitis C virus (HCV) after an allogeneic bone marrow transplant, the first such cases reported in Japan. Both had developed posttransfusion hepatitis during chemotherapy to induce remission and for consolidation. Six months after blood transfusion, the blood serum of each patient was positive for HCV antibody and HCV RNA. In each case, there was a transient improvement in liver function after the transplant. However, within 5 months of receiving the transplant and coincident with the withdrawal of cyclosporin A, each patient developed an acute exacerbation of hepatitis. The fulminant hepatitis in our patients may, therefore, have been caused by the reactivation of HCV induced by the immunosuppressive therapy followed by a reconstitution of the immune system.
Kanamori
H
H
Department of Hematology/Chemotherapy, Kanagawa Cancer Center, Yokohama, Japan.
Fukawa
H
H
Maruta
A
A
Harano
H
H
Kodama
F
F
Matsuzaki
M
M
Miyashita
H
H
Motomura
S
S
Okubo
T
T
Yoshiba
M
M
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects; D005260:Female; D006526:Hepatitis C / Q000209:etiology*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000601:surgery; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D008297:Male
D016572:Cyclosporine